ramucirumab (Q7290345)

DrugBank

European Medicines Agency product number

17 November 2015

1 reference

EMEA/H/C/002829

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002829/human_med_001825.jsp

World Health Organisation international non-proprietary name

22 March 2017

ramucirumab (English)

1 reference

Ramucirumab (English)

medical condition treated

19 January 2016

colon cancer

1 reference

Drug Indications Extracted from FAERS

non-small-cell lung carcinoma

2 October 2018

1 reference

Drug Indications Extracted from FAERS

2 October 2018

gastric adenocarcinoma

1 reference

Drug Indications Extracted from FAERS

LiverTox likelihood score

2 October 2018

Լյարդի ախտահարման հավանականության E կատեգորիա

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ramucirumab

29 May 2017

1 reference

Ramucirumab (English)

DrugBank

17 November 2015

1 reference

Medical Subject Headings

15 March 2018

1 reference

Ramucirumab (English)

publication date

17 November 2015

has part(s)

carbon

0 references

Identifiers

1 reference

Ramucirumab (English)

17 November 2015

1 reference

Hazardous Substances Data Bank

Ramucirumab (English)

19 January 2016

1 reference

28 October 2019

Ramucirumab (English)

10 May 2021

0 references

0 references

0 references

Guide to Pharmacology Ligand ID

0 references

Ramucirumab

0 references

MeSH tree code

D12.776.124.486.485.114.224.060.866

broader concept

humanized antibody

0 references

D12.776.124.790.651.114.224.060.866

broader concept

humanized antibody

0 references

D12.776.377.715.548.114.224.200.866

0 references

1 reference

26 February 2018

0 references

1 reference

RAMUCIRUMAB (English)

MedlinePlus drug identifier

19 January 2016

0 references

1 reference

RAMUCIRUMAB (English)

19 January 2016

1 reference

Ramucirumab (English)